A study found that the government spends .7 billion more to treat people with the disease, or some 12 percent of the 5 billion in total federal health care spending per fiscal year.
Since most diabetes cases are type II and form the biggest portion of diabetes costs, should research be targeted to determing more cost-effective and safe glucose monitoring and insulin delivery devices?